One of the earliest signs that the kidneys are not functioning the way they should, is the leaking of protein into the urine, ...
SGLT2 inhibitors are a welcome addition to GN care, but the field is still grappling with the gap between molecular ...
Recor Medical said today that it secured Medicare approval, granting coverage for the company's RADIANCE CED study.
Chronic kidney disease is a gradual, irreversible loss of kidney function caused by diabetes, hypertension, or ageing. It leads to waste accumulation, fatigue, swelling, and anaemia. Early detection, ...
Findings Published in The Journal of the American College of Cardiology Suggest Renal Denervation Could Substantially Reduce Cardiovascular Morbidity and Mortality for Patients with a Condition that ...
Credit: Recor Medical. The approval was based on data from the RADIANCE II trial which included patient with mild to moderate hypertension who were adequately controlled with medications. The Food and ...
Advisors on the US Food and Drug Administration’s Circulatory System Devices Panel voted today in support of the premarket approval (PMA) application for the Paradise Ultrasound Renal Denervation ...
A real-world study finds favorable stone-free rates after use of SURE with the CVAC® system to treat kidney stone burdens typically less than 2 cm. Despite its relatively novel status, steerable ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The latest edition of the United States Renal Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback